🇺🇸 FDA

Company profile · Sponsor

Centus

Centus Biotherapeutics Europe Limited

EFD9A06 · EMA pharma GB
Pipeline
1
Drugs
0
Patents
0

Quick answer

Centus (EFD9A06) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EFD9A06
Exchange EMA
Company type pharma
Headquarters GB

Pipeline (1)

Search pipeline →

  1. FKB238 (bevacizumab)

    Centus

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is Centus?

Centus (EFD9A06) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Centus sponsor?

We track 1 ClinicalTrials.gov-linked program for Centus, including FKB238 (bevacizumab). Open each program for phase, modality, NCT IDs, and indication details.

Where does Centus company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.